Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

VALRUBICIN for Bladder cancer: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 41 adverse event reports in the FDA FAERS database where VALRUBICIN was used for Bladder cancer.

Most Reported Side Effects for VALRUBICIN

Side Effect Reports % Deaths Hosp.
Bladder instillation procedure 20 26.0% 1 1
Underdose 18 23.4% 1 1
Urge incontinence 17 22.1% 1 1
Bladder spasm 8 10.4% 0 0
Drug ineffective 7 9.1% 0 0
Urinary incontinence 6 7.8% 0 0

Other Indications for VALRUBICIN

Product used for unknown indication (23) Bladder cancer stage 0, with cancer in situ (5)

Other Drugs Used for Bladder cancer

BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN (1,279) PEMBROLIZUMAB (869) GEMCITABINE (841) CISPLATIN (780) ENFORTUMAB VEDOTIN-EJFV (530) NIVOLUMAB (512) ATEZOLIZUMAB (487) CARBOPLATIN (332) BACILLUS CALMETTE-GUERIN ANTIGEN, UNSPECIFIED SUBSTRAIN (326) GEMCITABINE\GEMCITABINE (240)

Related Pages

VALRUBICIN Full Profile All Bladder cancer Drugs VALRUBICIN Demographics VALRUBICIN Timeline